TenX Keane Acquisition

The momentum for this stock is not very good. TenX Keane Acquisition is not very popular among insiders. Tradey thinks it is not wise to invest in TenX Keane Acquisition.

News

Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.

PR Newswire Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc. Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc...\n more…

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

Globe Newswire TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...\n more…

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.

PR Newswire Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc. Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology...\n more…

Virtu Financial LLC Takes Position in TenX Keane Acquisition (NASDAQ:TENK)

Zolmax Virtu Financial LLC bought a new position in shares of TenX Keane Acquisition (NASDAQ:TENK - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The...\n more…

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

PR Newswire Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates PR Newswire CRANFORD, N.J., July 10, 2024...\n more…